Patent applications and USPTO patent grants for Shin; Hye Jeong.The latest application filed is for "novel compound and pharmaceutical composition comprising same".
Patent | Date |
---|---|
Compound and pharmaceutical composition comprising same Grant 11,407,744 - Kim , et al. August 9, 2 | 2022-08-09 |
Novel Compound And Pharmaceutical Composition Comprising Same App 20210078987 - KIM; Jung Ju ;   et al. | 2021-03-18 |
Pillow App 20190343718 - SHIN; Hye Jeong ;   et al. | 2019-11-14 |
Human interleukin-1 receptor antagonist--hybrid Fc fusion protein Grant 8,883,134 - Cho , et al. November 11, 2 | 2014-11-11 |
Human Interleukin-1 Receptor Antagonist - Hybrid Fc Fusion Protein App 20130217864 - Cho; Young Gyu ;   et al. | 2013-08-22 |
Novel Cationic Lipid, A Preparation Method of the Same and A Delivery System Comprising the Same App 20120021044 - Oh; Yu-Kyoung ;   et al. | 2012-01-26 |
Composition Of Cationic Phospholipid Nanoparticles For Effective Delivery Of Nucleic Acids App 20100203112 - Oh; Yu-Kyoung ;   et al. | 2010-08-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.